Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

The "etymology" in Ovid Heroides 20.21-32

Bibliographic Data

ID11783232
AuthorsFrancis Cairns (corresponding author), Ariz Akhter (Division of Hematology and Transfusion Medicine, Department of Pathology and Laboratory Medicine University of Calgary/Calgary Laboratory Services (CLS) Calgary Alberta Canada), Lesley Street (Division of Hematology and Hematologic Malignancies, Tom Baker Cancer Center University of Calgary Calgary Alberta Canada), Sunita Ghosh (0000-0002-9763-5058, Department of Biostatistics, Cross Cancer Institute University of Alberta Edmonton Alberta Canada), Bruce F Burns (Department of Pathology and Laboratory Medicine University of Ottawa Ottawa Ontario Canada), Ghaleb Elyamany (Department of Pathology and Laboratory Medicine Prince Sultan Military Medical City Riyadh Saudi Arabia), Meer‐Taher Shabani‐Rad (Division of Hematology and Transfusion Medicine, Department of Pathology and Laboratory Medicine University of Calgary/Calgary Laboratory Services (CLS) Calgary Alberta Canada), Douglas A Stewart (0000-0001-5531-0960, Division of Hematology and Hematologic Malignancies, Tom Baker Cancer Center University of Calgary Calgary Alberta Canada), Adnan Mansoor (Division of Hematology and Transfusion Medicine, Department of Pathology and Laboratory Medicine University of Calgary/Calgary Laboratory Services (CLS) Calgary Alberta Canada)
Year2003
Volume98
Issue3
Pages239-242
Publication date2003-01-01
Open AccessYes
TypeARTICLE
VenueThe Classical Journal (JOURNAL)
Journal identifiersISSN: 0009-8353 • E-ISSN: 2327-5812
PublisherClassical Association of the Middle West and South (PUBLISHER • US)
DOI10.1002/hon.2251
OpenAlexW26354285
LanguageEN
References cited38

Mantle cell lymphoma (MCL) is an aggressive disease with frequent relapse. Targeted therapies against B-cell receptor (BCR) molecules have demonstrated improved outcomes in relapsed cases. However, clinical responses are slow and selective, with failure to attain complete remission in a significant subset of patients. Complex interaction of BCR signal transduction with toll-like receptor (TLR) and other pathways in MCL remains unknown, thus averting progress in development of targeted therapies. We have performed detailed digital quantification of BCR/TLR signalling molecules and their effector pathways in a cohort (n = 81) of MCL patients and correlated these data with overall survival. Hierarchical clustering model based on BCR/TLR genes revealed two distinct (BCR high and BCR low ) subsets of patients (n = 32; 40%) with significant differences in expression (>1.5-fold change; p high subset of MCL patients. On univariate analysis, the BCR high patients showed a trend towards inferior clinical response to a standardized treatment protocol, compared with the BCR low group (log rank, p = 0.043). In conclusion, we have identified hyperactive BCR/TLR signalling pathways and their effector downstream targets in a subset of MCL patients and associated it with poor clinical outcomes. Our study provides quantitative evidence at RNA expression level of possible concomitant collaboration between TLR and BCR signalling molecules in MCL. These data will provide further insights for future functional studies and, hence, development of targeted therapies for MCL patients. Copyright © 2015 John Wiley & Sons, Ltd

Art · Etymology · Linguistics · Literature · Ancient Near East History · Classical Antiquity Studies · Historical, Religious, and Philosophical Studies · History · Philosophy

Highly citedNo

Tools

Open DOISci-Hub
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae